Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis.
Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis.
复制标题
DOI:
10.1007/s00415-022-11195-8
复制
发表时间:
2022-10
影响因子:
6
通讯作者:
Thompson, Alexander G.
中科院分区:
文献类型:
--
作者:
Gao, Jiali;Dharmadasa, Thanuja;Malaspina, Andrea;Shaw, Pamela J.;Talbot, Kevin;Turner, Martin R.;Thompson, Alexander G.
Amyotrophic lateral sclerosis (ALS) is a prognostically heterogeneous neurodegenerative disease. Blood creatine kinase (CK) level has been inconsistently reported as a prognostic biomarker and raised levels in some ALS patients have been presumed to reflect muscle wasting, which is also variable. MEDLINE was systematically searched for papers related to CK in ALS and the relevant studies were reviewed. Using data from 222 ALS patients in a multi-centre, prospective, longitudinal cohort, survival analyses using Kaplan–Meier and Cox proportional hazards models were undertaken in relation to CK and other prognostic factors. Twenty-five studies investigating CK in ALS were identified, of which 10 specifically studied the link between CK and survival. Five studies observed no association, four found that higher CK levels were associated with longer survival and one, the opposite. In our cohort (n = 222), 39% of patients had a CK level above the laboratory reference range. Levels were higher in males compared to females (p < 0.001), in patients with limb versus bulbar onset of symptoms (p < 0.001) and in patients with higher lower motor neuron burden (p < 0.001). There was no significant trend in longitudinal CK values. Although a higher standardised log (CK) at first visit was associated with longer survival in univariate analysis (hazard ratio 0.75, p = 0.003), there was no significant association after adjusting for other prognostic covariates. While raised CK levels in ALS do reflect lower motor neuron denervation to a large extent, they are not independently associated with survival when measured in the symptomatic phase of the disease. The online version contains supplementary material available at 10.1007/s00415-022-11195-8.
登录
查看更多内容
影响因子:
4.8
作者:
Thompson AG;Gray E;Verber N;Bobeva Y;Lombardi V;Shepheard SR;Yildiz O;Feneberg E;Farrimond L;Dharmadasa T;Gray P;Edmond EC;Scaber J;Gagliardi D;Kirby J;Jenkins TM;Fratta P;McDermott CJ;Manohar SG;Talbot K;Malaspina A;Shaw PJ;Turner MR
通讯作者:
Turner MR
影响因子:
11.2
作者:
Benatar, Michael;Wuu, Joanne;Malaspina, Andrea
通讯作者:
Malaspina, Andrea
DOI:
10.3109/17482960802566824
发表时间:
2009-10
期刊:
Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
影响因子:
--
作者:
Chiò A;Logroscino G;Hardiman O;Swingler R;Mitchell D;Beghi E;Traynor BG;Eurals Consortium
通讯作者:
Eurals Consortium
影响因子:
6.1
作者:
Moghadam-Kia S;Oddis CV;Aggarwal R
通讯作者:
Aggarwal R
DOI:
10.3109/21678421.2015.1062516
发表时间:
2015
影响因子:
2.8
作者:
Gibson SB;Kasarskis EJ;Hu N;Pulst SM;Mendiondo MS;Matthews DE;Mitsumoto H;Tandan R;Simmons Z;Kryscio RJ;Bromberg MB
通讯作者:
Bromberg MB